Saltagen Ventures

Saltagen Ventures Limited is a trans-Pacific early-stage venture capital firm founded in 2017 and headquartered in Central, Hong Kong. Founded by Managing Partner Joseph Fung, the firm is built around a distinctive thesis of bridging North American innovation with Asian markets — backing founders whose companies can scale across the Pacific in both directions. Fung is joined by Chief Operating Officer Simon Lai and Partner Emmanuel Hui, who also serves as CEO of Saltagen's affiliated accelerator Pebble. The 18-person team brings operational depth across the firm's four sector verticals: edtech, biomedical technology and life sciences, artificial intelligence and machine learning, and media technology. Saltagen leads rounds and invests from pre-seed through Series A, with initial check sizes ranging from $100,000 to $5 million and a sweet spot around $1.5 million. The strategy reserves follow-on capital specifically to drive exits — investing early, maintaining dry powder, and doubling down on winners in partnership with founders and the firm's trans-Pacific network. Across approximately 25 disclosed investments, notable portfolio companies include PulseMedica (diagnostic equipment), modl.ai (gaming AI), Oncoustics (health AI), Fano Labs (Hong Kong speech AI), Sympatic, and Beatdapp. Primary deployment has concentrated on Canada-based and North American startups with Asia-Pacific expansion potential. Saltagen's edge is structural: the firm connects founders to capital sources and distribution channels on both sides of the Pacific that would otherwise require years to build independently. By embedding deeply in both the North American startup corridor and Hong Kong's regional gateway, Saltagen positions portfolio companies for earlier and more durable cross-border growth than either ecosystem could offer alone.